Advanced

The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma

Bjork-Eriksson, T; Bjelkengren, Göran LU and Glimelius, B (2005) In Acta Oncologica 44(8). p.913-917
Abstract
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. Besides sarcomas of the base of skull, which are classical sites for proton beam therapy, it is estimated that about 40 patients yearly in Sweden with sarcomas at other sites are candidates for proton beam therapy. About 20 patients each with malignant lymphomas, chiefly in the mediastinum, and thymomas are also... (More)
A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. Besides sarcomas of the base of skull, which are classical sites for proton beam therapy, it is estimated that about 40 patients yearly in Sweden with sarcomas at other sites are candidates for proton beam therapy. About 20 patients each with malignant lymphomas, chiefly in the mediastinum, and thymomas are also candidates to decrease doses to surrounding heart and lungs. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Oncologica
volume
44
issue
8
pages
913 - 917
publisher
Taylor & Francis
external identifiers
  • wos:000233855500017
  • pmid:16332601
  • scopus:28844507586
ISSN
1651-226X
DOI
10.1080/02841860500355983
language
English
LU publication?
yes
id
f7149d9b-cc1a-40f9-99f7-ab5670df68e9 (old id 894367)
date added to LUP
2008-01-11 11:51:28
date last changed
2017-01-01 07:17:09
@article{f7149d9b-cc1a-40f9-99f7-ab5670df68e9,
  abstract     = {A group of Swedish oncologists and hospital physicists have estimated the number of patients in Sweden suitable for proton beam therapy. The estimations have been based on current statistics of tumour incidence, number of patients potentially eligible for radiation treatment, scientific support from clinical trials and model dose planning studies and knowledge of the dose-response relations of different tumours and normal tissues. Besides sarcomas of the base of skull, which are classical sites for proton beam therapy, it is estimated that about 40 patients yearly in Sweden with sarcomas at other sites are candidates for proton beam therapy. About 20 patients each with malignant lymphomas, chiefly in the mediastinum, and thymomas are also candidates to decrease doses to surrounding heart and lungs.},
  author       = {Bjork-Eriksson, T and Bjelkengren, Göran and Glimelius, B},
  issn         = {1651-226X},
  language     = {eng},
  number       = {8},
  pages        = {913--917},
  publisher    = {Taylor & Francis},
  series       = {Acta Oncologica},
  title        = {The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma},
  url          = {http://dx.doi.org/10.1080/02841860500355983},
  volume       = {44},
  year         = {2005},
}